The SGK1 inhibitor SI113 induces autophagy, apoptosis, and endoplasmic reticulum stress in endometrial cancer cells

Endometrial cancer is often characterized by PI3K/AKT pathway deregulation. Recently it has been suggested that SGK1, a serine/threonine protein kinase that shares structural and functional similarities with the AKT family, might play a role in cancer, since its expression and/or activity has been f...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cellular physiology 2017-12, Vol.232 (12), p.3735-3743
Hauptverfasser: Conza, Domenico, Mirra, Paola, Calì, Gaetano, Tortora, Teresa, Insabato, Luigi, Fiory, Francesca, Schenone, Silvia, Amato, Rosario, Beguinot, Francesco, Perrotti, Nicola, Ulianich, Luca
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3743
container_issue 12
container_start_page 3735
container_title Journal of cellular physiology
container_volume 232
creator Conza, Domenico
Mirra, Paola
Calì, Gaetano
Tortora, Teresa
Insabato, Luigi
Fiory, Francesca
Schenone, Silvia
Amato, Rosario
Beguinot, Francesco
Perrotti, Nicola
Ulianich, Luca
description Endometrial cancer is often characterized by PI3K/AKT pathway deregulation. Recently it has been suggested that SGK1, a serine/threonine protein kinase that shares structural and functional similarities with the AKT family, might play a role in cancer, since its expression and/or activity has been found to be deregulated in different human tumors. However, the role of SGK1 in endometrial cancer has been poorly investigated. Here, we show that SGK1 expression is increased in tissue specimens from neoplastic endometrium. The SGK1 inhibitor SI113 induced a significant reduction of endometrial cancer cells viability, measured by the (3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyl tetrazolium bromide assay. This effect was associated to the increase of autophagy, as revealed by the increase of the markers LC3B‐II and beclin I, detected by both immunofluorescence and western blot analysis. SI113 treatment caused also apoptosis of endometrial cancer cells, evidenced by the cleavage of the apoptotic markers PARP and Caspase‐9. Intriguingly, these effects were associated to the induction of endoplasmic reticulum stress markers GRP78 and CHOP evaluated by both Real‐Time RT‐PCR and Western Blot analysis. Increased expression of SGK1 in endometrial cancer tissues suggest a role for SGK1 in this type of cancer, as reported for other malignancies. Moreover, the efficacy of SI113 in affecting endometrial cancer cells viability, possibly via endoplasmic reticulum stress activation, identifies SGK1 as an attractive molecular target for new tailored therapeutic intervention for the treatment of endometrial cancer. SGK1 expression is increased in endometrial cancer SI113, an inhibitor of SGK1, induces endoplasmic reticulum stress, autophagy, and apoptosis in endometrial cancer cells.
doi_str_mv 10.1002/jcp.25850
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1930914055</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1930914055</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3530-547c49cc6d25a5d727c70d72a397eba339843e16e54d0c7388580866b6ede7323</originalsourceid><addsrcrecordid>eNp1kFFLwzAUhYMobk4f_AMS8EmwW9I0TfMoQ-d0oLD5XLL0zmW0TU1aZP_euKpvPp17Od89Fw5Cl5SMKSHxZKebccwzTo7QkBIpoiTl8TEaBo9Gkid0gM683xFCpGTsFA3ijApB42yI_GoLeDl7ptjUW7M2rXV4OaeUhb3oNHisutY2W_W-v8WqsU1rvfFhrAsMdWGbUvnKaOygNboruwr71oH34fzgV9A6o0qsVa3BYQ1l6c_RyUaVHi5-dITeHu5X08do8TKbT-8WkWackYgnQidS67SIueKFiIUWJIhiUsBaMSazhAFNgScF0YJlGc9IlqbrFAoQLGYjdN3nNs5-dODbfGc7V4eXOZWMSJoQzgN101PaWe8dbPLGmUq5fU5J_l1vHurND_UG9uonsVtXUPyRv30GYNIDn6aE_f9J-dP0tY_8Akftg1k</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1930914055</pqid></control><display><type>article</type><title>The SGK1 inhibitor SI113 induces autophagy, apoptosis, and endoplasmic reticulum stress in endometrial cancer cells</title><source>Wiley Online Library - AutoHoldings Journals</source><source>MEDLINE</source><creator>Conza, Domenico ; Mirra, Paola ; Calì, Gaetano ; Tortora, Teresa ; Insabato, Luigi ; Fiory, Francesca ; Schenone, Silvia ; Amato, Rosario ; Beguinot, Francesco ; Perrotti, Nicola ; Ulianich, Luca</creator><creatorcontrib>Conza, Domenico ; Mirra, Paola ; Calì, Gaetano ; Tortora, Teresa ; Insabato, Luigi ; Fiory, Francesca ; Schenone, Silvia ; Amato, Rosario ; Beguinot, Francesco ; Perrotti, Nicola ; Ulianich, Luca</creatorcontrib><description>Endometrial cancer is often characterized by PI3K/AKT pathway deregulation. Recently it has been suggested that SGK1, a serine/threonine protein kinase that shares structural and functional similarities with the AKT family, might play a role in cancer, since its expression and/or activity has been found to be deregulated in different human tumors. However, the role of SGK1 in endometrial cancer has been poorly investigated. Here, we show that SGK1 expression is increased in tissue specimens from neoplastic endometrium. The SGK1 inhibitor SI113 induced a significant reduction of endometrial cancer cells viability, measured by the (3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyl tetrazolium bromide assay. This effect was associated to the increase of autophagy, as revealed by the increase of the markers LC3B‐II and beclin I, detected by both immunofluorescence and western blot analysis. SI113 treatment caused also apoptosis of endometrial cancer cells, evidenced by the cleavage of the apoptotic markers PARP and Caspase‐9. Intriguingly, these effects were associated to the induction of endoplasmic reticulum stress markers GRP78 and CHOP evaluated by both Real‐Time RT‐PCR and Western Blot analysis. Increased expression of SGK1 in endometrial cancer tissues suggest a role for SGK1 in this type of cancer, as reported for other malignancies. Moreover, the efficacy of SI113 in affecting endometrial cancer cells viability, possibly via endoplasmic reticulum stress activation, identifies SGK1 as an attractive molecular target for new tailored therapeutic intervention for the treatment of endometrial cancer. SGK1 expression is increased in endometrial cancer SI113, an inhibitor of SGK1, induces endoplasmic reticulum stress, autophagy, and apoptosis in endometrial cancer cells.</description><identifier>ISSN: 0021-9541</identifier><identifier>EISSN: 1097-4652</identifier><identifier>DOI: 10.1002/jcp.25850</identifier><identifier>PMID: 28177128</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>1-Phosphatidylinositol 3-kinase ; AKT protein ; Antineoplastic Agents - pharmacology ; Apoptosis ; Apoptosis - drug effects ; Autophagy ; Autophagy - drug effects ; Beclin-1 - metabolism ; Cancer ; Case-Control Studies ; Caspase ; Caspase 9 - metabolism ; Caspase-9 ; Cell Line, Tumor ; Cell Survival - drug effects ; Deregulation ; Dose-Response Relationship, Drug ; Endometrial cancer ; Endometrial Neoplasms - drug therapy ; Endometrial Neoplasms - enzymology ; Endometrial Neoplasms - genetics ; Endometrial Neoplasms - pathology ; Endometrium ; Endoplasmic reticulum ; endoplasmic reticulum stress ; Endoplasmic Reticulum Stress - drug effects ; Female ; Heat-Shock Proteins - genetics ; Heat-Shock Proteins - metabolism ; Humans ; Immediate-Early Proteins - antagonists &amp; inhibitors ; Immediate-Early Proteins - metabolism ; Immunofluorescence ; Inhibitors ; Kinases ; Markers ; Microtubule-Associated Proteins - metabolism ; Middle Aged ; Phagocytosis ; Poly(ADP-ribose) polymerase ; Poly(ADP-ribose) Polymerases - metabolism ; Polymerase chain reaction ; Protein kinase ; Protein Kinase Inhibitors - pharmacology ; Protein-Serine-Threonine Kinases - antagonists &amp; inhibitors ; Protein-Serine-Threonine Kinases - metabolism ; Protein-serine/threonine kinase ; Pyrazoles - pharmacology ; Pyrimidines - pharmacology ; SGK1 ; Signal Transduction - drug effects ; Stresses ; Structure-function relationships ; Transcription Factor CHOP - genetics ; Transcription Factor CHOP - metabolism ; Tumors ; Viability</subject><ispartof>Journal of cellular physiology, 2017-12, Vol.232 (12), p.3735-3743</ispartof><rights>2017 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3530-547c49cc6d25a5d727c70d72a397eba339843e16e54d0c7388580866b6ede7323</citedby><cites>FETCH-LOGICAL-c3530-547c49cc6d25a5d727c70d72a397eba339843e16e54d0c7388580866b6ede7323</cites><orcidid>0000-0002-8496-3538</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjcp.25850$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjcp.25850$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28177128$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Conza, Domenico</creatorcontrib><creatorcontrib>Mirra, Paola</creatorcontrib><creatorcontrib>Calì, Gaetano</creatorcontrib><creatorcontrib>Tortora, Teresa</creatorcontrib><creatorcontrib>Insabato, Luigi</creatorcontrib><creatorcontrib>Fiory, Francesca</creatorcontrib><creatorcontrib>Schenone, Silvia</creatorcontrib><creatorcontrib>Amato, Rosario</creatorcontrib><creatorcontrib>Beguinot, Francesco</creatorcontrib><creatorcontrib>Perrotti, Nicola</creatorcontrib><creatorcontrib>Ulianich, Luca</creatorcontrib><title>The SGK1 inhibitor SI113 induces autophagy, apoptosis, and endoplasmic reticulum stress in endometrial cancer cells</title><title>Journal of cellular physiology</title><addtitle>J Cell Physiol</addtitle><description>Endometrial cancer is often characterized by PI3K/AKT pathway deregulation. Recently it has been suggested that SGK1, a serine/threonine protein kinase that shares structural and functional similarities with the AKT family, might play a role in cancer, since its expression and/or activity has been found to be deregulated in different human tumors. However, the role of SGK1 in endometrial cancer has been poorly investigated. Here, we show that SGK1 expression is increased in tissue specimens from neoplastic endometrium. The SGK1 inhibitor SI113 induced a significant reduction of endometrial cancer cells viability, measured by the (3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyl tetrazolium bromide assay. This effect was associated to the increase of autophagy, as revealed by the increase of the markers LC3B‐II and beclin I, detected by both immunofluorescence and western blot analysis. SI113 treatment caused also apoptosis of endometrial cancer cells, evidenced by the cleavage of the apoptotic markers PARP and Caspase‐9. Intriguingly, these effects were associated to the induction of endoplasmic reticulum stress markers GRP78 and CHOP evaluated by both Real‐Time RT‐PCR and Western Blot analysis. Increased expression of SGK1 in endometrial cancer tissues suggest a role for SGK1 in this type of cancer, as reported for other malignancies. Moreover, the efficacy of SI113 in affecting endometrial cancer cells viability, possibly via endoplasmic reticulum stress activation, identifies SGK1 as an attractive molecular target for new tailored therapeutic intervention for the treatment of endometrial cancer. SGK1 expression is increased in endometrial cancer SI113, an inhibitor of SGK1, induces endoplasmic reticulum stress, autophagy, and apoptosis in endometrial cancer cells.</description><subject>1-Phosphatidylinositol 3-kinase</subject><subject>AKT protein</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Apoptosis</subject><subject>Apoptosis - drug effects</subject><subject>Autophagy</subject><subject>Autophagy - drug effects</subject><subject>Beclin-1 - metabolism</subject><subject>Cancer</subject><subject>Case-Control Studies</subject><subject>Caspase</subject><subject>Caspase 9 - metabolism</subject><subject>Caspase-9</subject><subject>Cell Line, Tumor</subject><subject>Cell Survival - drug effects</subject><subject>Deregulation</subject><subject>Dose-Response Relationship, Drug</subject><subject>Endometrial cancer</subject><subject>Endometrial Neoplasms - drug therapy</subject><subject>Endometrial Neoplasms - enzymology</subject><subject>Endometrial Neoplasms - genetics</subject><subject>Endometrial Neoplasms - pathology</subject><subject>Endometrium</subject><subject>Endoplasmic reticulum</subject><subject>endoplasmic reticulum stress</subject><subject>Endoplasmic Reticulum Stress - drug effects</subject><subject>Female</subject><subject>Heat-Shock Proteins - genetics</subject><subject>Heat-Shock Proteins - metabolism</subject><subject>Humans</subject><subject>Immediate-Early Proteins - antagonists &amp; inhibitors</subject><subject>Immediate-Early Proteins - metabolism</subject><subject>Immunofluorescence</subject><subject>Inhibitors</subject><subject>Kinases</subject><subject>Markers</subject><subject>Microtubule-Associated Proteins - metabolism</subject><subject>Middle Aged</subject><subject>Phagocytosis</subject><subject>Poly(ADP-ribose) polymerase</subject><subject>Poly(ADP-ribose) Polymerases - metabolism</subject><subject>Polymerase chain reaction</subject><subject>Protein kinase</subject><subject>Protein Kinase Inhibitors - pharmacology</subject><subject>Protein-Serine-Threonine Kinases - antagonists &amp; inhibitors</subject><subject>Protein-Serine-Threonine Kinases - metabolism</subject><subject>Protein-serine/threonine kinase</subject><subject>Pyrazoles - pharmacology</subject><subject>Pyrimidines - pharmacology</subject><subject>SGK1</subject><subject>Signal Transduction - drug effects</subject><subject>Stresses</subject><subject>Structure-function relationships</subject><subject>Transcription Factor CHOP - genetics</subject><subject>Transcription Factor CHOP - metabolism</subject><subject>Tumors</subject><subject>Viability</subject><issn>0021-9541</issn><issn>1097-4652</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kFFLwzAUhYMobk4f_AMS8EmwW9I0TfMoQ-d0oLD5XLL0zmW0TU1aZP_euKpvPp17Od89Fw5Cl5SMKSHxZKebccwzTo7QkBIpoiTl8TEaBo9Gkid0gM683xFCpGTsFA3ijApB42yI_GoLeDl7ptjUW7M2rXV4OaeUhb3oNHisutY2W_W-v8WqsU1rvfFhrAsMdWGbUvnKaOygNboruwr71oH34fzgV9A6o0qsVa3BYQ1l6c_RyUaVHi5-dITeHu5X08do8TKbT-8WkWackYgnQidS67SIueKFiIUWJIhiUsBaMSazhAFNgScF0YJlGc9IlqbrFAoQLGYjdN3nNs5-dODbfGc7V4eXOZWMSJoQzgN101PaWe8dbPLGmUq5fU5J_l1vHurND_UG9uonsVtXUPyRv30GYNIDn6aE_f9J-dP0tY_8Akftg1k</recordid><startdate>201712</startdate><enddate>201712</enddate><creator>Conza, Domenico</creator><creator>Mirra, Paola</creator><creator>Calì, Gaetano</creator><creator>Tortora, Teresa</creator><creator>Insabato, Luigi</creator><creator>Fiory, Francesca</creator><creator>Schenone, Silvia</creator><creator>Amato, Rosario</creator><creator>Beguinot, Francesco</creator><creator>Perrotti, Nicola</creator><creator>Ulianich, Luca</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>RC3</scope><orcidid>https://orcid.org/0000-0002-8496-3538</orcidid></search><sort><creationdate>201712</creationdate><title>The SGK1 inhibitor SI113 induces autophagy, apoptosis, and endoplasmic reticulum stress in endometrial cancer cells</title><author>Conza, Domenico ; Mirra, Paola ; Calì, Gaetano ; Tortora, Teresa ; Insabato, Luigi ; Fiory, Francesca ; Schenone, Silvia ; Amato, Rosario ; Beguinot, Francesco ; Perrotti, Nicola ; Ulianich, Luca</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3530-547c49cc6d25a5d727c70d72a397eba339843e16e54d0c7388580866b6ede7323</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>1-Phosphatidylinositol 3-kinase</topic><topic>AKT protein</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Apoptosis</topic><topic>Apoptosis - drug effects</topic><topic>Autophagy</topic><topic>Autophagy - drug effects</topic><topic>Beclin-1 - metabolism</topic><topic>Cancer</topic><topic>Case-Control Studies</topic><topic>Caspase</topic><topic>Caspase 9 - metabolism</topic><topic>Caspase-9</topic><topic>Cell Line, Tumor</topic><topic>Cell Survival - drug effects</topic><topic>Deregulation</topic><topic>Dose-Response Relationship, Drug</topic><topic>Endometrial cancer</topic><topic>Endometrial Neoplasms - drug therapy</topic><topic>Endometrial Neoplasms - enzymology</topic><topic>Endometrial Neoplasms - genetics</topic><topic>Endometrial Neoplasms - pathology</topic><topic>Endometrium</topic><topic>Endoplasmic reticulum</topic><topic>endoplasmic reticulum stress</topic><topic>Endoplasmic Reticulum Stress - drug effects</topic><topic>Female</topic><topic>Heat-Shock Proteins - genetics</topic><topic>Heat-Shock Proteins - metabolism</topic><topic>Humans</topic><topic>Immediate-Early Proteins - antagonists &amp; inhibitors</topic><topic>Immediate-Early Proteins - metabolism</topic><topic>Immunofluorescence</topic><topic>Inhibitors</topic><topic>Kinases</topic><topic>Markers</topic><topic>Microtubule-Associated Proteins - metabolism</topic><topic>Middle Aged</topic><topic>Phagocytosis</topic><topic>Poly(ADP-ribose) polymerase</topic><topic>Poly(ADP-ribose) Polymerases - metabolism</topic><topic>Polymerase chain reaction</topic><topic>Protein kinase</topic><topic>Protein Kinase Inhibitors - pharmacology</topic><topic>Protein-Serine-Threonine Kinases - antagonists &amp; inhibitors</topic><topic>Protein-Serine-Threonine Kinases - metabolism</topic><topic>Protein-serine/threonine kinase</topic><topic>Pyrazoles - pharmacology</topic><topic>Pyrimidines - pharmacology</topic><topic>SGK1</topic><topic>Signal Transduction - drug effects</topic><topic>Stresses</topic><topic>Structure-function relationships</topic><topic>Transcription Factor CHOP - genetics</topic><topic>Transcription Factor CHOP - metabolism</topic><topic>Tumors</topic><topic>Viability</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Conza, Domenico</creatorcontrib><creatorcontrib>Mirra, Paola</creatorcontrib><creatorcontrib>Calì, Gaetano</creatorcontrib><creatorcontrib>Tortora, Teresa</creatorcontrib><creatorcontrib>Insabato, Luigi</creatorcontrib><creatorcontrib>Fiory, Francesca</creatorcontrib><creatorcontrib>Schenone, Silvia</creatorcontrib><creatorcontrib>Amato, Rosario</creatorcontrib><creatorcontrib>Beguinot, Francesco</creatorcontrib><creatorcontrib>Perrotti, Nicola</creatorcontrib><creatorcontrib>Ulianich, Luca</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>Journal of cellular physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Conza, Domenico</au><au>Mirra, Paola</au><au>Calì, Gaetano</au><au>Tortora, Teresa</au><au>Insabato, Luigi</au><au>Fiory, Francesca</au><au>Schenone, Silvia</au><au>Amato, Rosario</au><au>Beguinot, Francesco</au><au>Perrotti, Nicola</au><au>Ulianich, Luca</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The SGK1 inhibitor SI113 induces autophagy, apoptosis, and endoplasmic reticulum stress in endometrial cancer cells</atitle><jtitle>Journal of cellular physiology</jtitle><addtitle>J Cell Physiol</addtitle><date>2017-12</date><risdate>2017</risdate><volume>232</volume><issue>12</issue><spage>3735</spage><epage>3743</epage><pages>3735-3743</pages><issn>0021-9541</issn><eissn>1097-4652</eissn><abstract>Endometrial cancer is often characterized by PI3K/AKT pathway deregulation. Recently it has been suggested that SGK1, a serine/threonine protein kinase that shares structural and functional similarities with the AKT family, might play a role in cancer, since its expression and/or activity has been found to be deregulated in different human tumors. However, the role of SGK1 in endometrial cancer has been poorly investigated. Here, we show that SGK1 expression is increased in tissue specimens from neoplastic endometrium. The SGK1 inhibitor SI113 induced a significant reduction of endometrial cancer cells viability, measured by the (3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyl tetrazolium bromide assay. This effect was associated to the increase of autophagy, as revealed by the increase of the markers LC3B‐II and beclin I, detected by both immunofluorescence and western blot analysis. SI113 treatment caused also apoptosis of endometrial cancer cells, evidenced by the cleavage of the apoptotic markers PARP and Caspase‐9. Intriguingly, these effects were associated to the induction of endoplasmic reticulum stress markers GRP78 and CHOP evaluated by both Real‐Time RT‐PCR and Western Blot analysis. Increased expression of SGK1 in endometrial cancer tissues suggest a role for SGK1 in this type of cancer, as reported for other malignancies. Moreover, the efficacy of SI113 in affecting endometrial cancer cells viability, possibly via endoplasmic reticulum stress activation, identifies SGK1 as an attractive molecular target for new tailored therapeutic intervention for the treatment of endometrial cancer. SGK1 expression is increased in endometrial cancer SI113, an inhibitor of SGK1, induces endoplasmic reticulum stress, autophagy, and apoptosis in endometrial cancer cells.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>28177128</pmid><doi>10.1002/jcp.25850</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-8496-3538</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0021-9541
ispartof Journal of cellular physiology, 2017-12, Vol.232 (12), p.3735-3743
issn 0021-9541
1097-4652
language eng
recordid cdi_proquest_journals_1930914055
source Wiley Online Library - AutoHoldings Journals; MEDLINE
subjects 1-Phosphatidylinositol 3-kinase
AKT protein
Antineoplastic Agents - pharmacology
Apoptosis
Apoptosis - drug effects
Autophagy
Autophagy - drug effects
Beclin-1 - metabolism
Cancer
Case-Control Studies
Caspase
Caspase 9 - metabolism
Caspase-9
Cell Line, Tumor
Cell Survival - drug effects
Deregulation
Dose-Response Relationship, Drug
Endometrial cancer
Endometrial Neoplasms - drug therapy
Endometrial Neoplasms - enzymology
Endometrial Neoplasms - genetics
Endometrial Neoplasms - pathology
Endometrium
Endoplasmic reticulum
endoplasmic reticulum stress
Endoplasmic Reticulum Stress - drug effects
Female
Heat-Shock Proteins - genetics
Heat-Shock Proteins - metabolism
Humans
Immediate-Early Proteins - antagonists & inhibitors
Immediate-Early Proteins - metabolism
Immunofluorescence
Inhibitors
Kinases
Markers
Microtubule-Associated Proteins - metabolism
Middle Aged
Phagocytosis
Poly(ADP-ribose) polymerase
Poly(ADP-ribose) Polymerases - metabolism
Polymerase chain reaction
Protein kinase
Protein Kinase Inhibitors - pharmacology
Protein-Serine-Threonine Kinases - antagonists & inhibitors
Protein-Serine-Threonine Kinases - metabolism
Protein-serine/threonine kinase
Pyrazoles - pharmacology
Pyrimidines - pharmacology
SGK1
Signal Transduction - drug effects
Stresses
Structure-function relationships
Transcription Factor CHOP - genetics
Transcription Factor CHOP - metabolism
Tumors
Viability
title The SGK1 inhibitor SI113 induces autophagy, apoptosis, and endoplasmic reticulum stress in endometrial cancer cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T14%3A23%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20SGK1%20inhibitor%20SI113%20induces%20autophagy,%20apoptosis,%20and%20endoplasmic%20reticulum%20stress%20in%20endometrial%20cancer%20cells&rft.jtitle=Journal%20of%20cellular%20physiology&rft.au=Conza,%20Domenico&rft.date=2017-12&rft.volume=232&rft.issue=12&rft.spage=3735&rft.epage=3743&rft.pages=3735-3743&rft.issn=0021-9541&rft.eissn=1097-4652&rft_id=info:doi/10.1002/jcp.25850&rft_dat=%3Cproquest_cross%3E1930914055%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1930914055&rft_id=info:pmid/28177128&rfr_iscdi=true